RYBELSUS 7 mg/1 (Oral Semaglutide TABLET) 7 mg/1

RYBELSUS 7 mg/1 is an oral tablet containing semaglutide, used for managing type 2 diabetes. This medication helps control blood sugar levels and supports weight management. Ideal for those seeking an oral GLP-1 receptor agonist.

Strength

7 mg/1

Pack Size

30 TABLET in 1 BOTTLE, GLASS (0169-4307-30)

Manufacturer / TM Owner

Novo Nordisk

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

RYBELSUS 7 mg/1 is primarily used for the management of type 2 diabetes in adults. It works by mimicking natural hormones in your body to lower blood sugar levels. This medication is often prescribed as part of a comprehensive treatment plan that includes diet and exercise. People may also use RYBELSUS for weight management, as it can help reduce appetite and promote weight loss.

Side Effects

Common effects of RYBELSUS 7 mg/1 may include nausea, vomiting, diarrhea, constipation, and abdominal pain. Some users experience a decrease in appetite, which can aid in weight management. These effects are generally mild and tend to diminish over time as the body adjusts to the medication.

Precautions & Warnings

RYBELSUS 7 mg/1 should be taken exactly as prescribed by a healthcare provider. It is important to follow the recommended dosage and administration instructions. This medication should be stored at room temperature, away from moisture and heat. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Avoid Interactions

RYBELSUS 7 mg/1 may interact with certain medications, including those that affect kidney function or other diabetes medications. Alcohol consumption should be moderated, as it can affect blood sugar levels. Always consult a healthcare provider before starting or stopping any medication while taking RYBELSUS.

Frequently Asked Questions

RYBELSUS 7 mg/1 is used for managing type 2 diabetes and supporting weight management.

RYBELSUS 7 mg/1 should be taken orally, with a sip of plain water, at least 30 minutes before the first food, beverage, or other oral medications of the day.

Common side effects include nausea, vomiting, diarrhea, constipation, and abdominal pain.

Always consult a healthcare provider before taking RYBELSUS 7 mg/1 with other medications to avoid potential interactions.

RYBELSUS 7 mg/1 is prescribed based on individual health conditions. Consult a healthcare provider to determine if it is suitable for you.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.